This article reviews the literature on the etiology and management of capsular contracture, focusing on indications for capsulectomy along with explantation of breast implants. This article outlines the clinical factors which should be considered when managing capsular contracture. This article offers the most comprehensive review to date of surgical and nonsurgical management of capsular contracture. The goal of treatment is to prevent recurrence of capsular contracture, minimize risk to the patient, and obtain esthetic results. Capsulectomy is indicated in the majority of cases when breast implants are being removed or replaced in the setting of contracture. However, the surgeon must consider the risks and benefits of capsulectomy.
SpearSLBakerJLJr.Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg. 1995;96(5):1119-1113; discussion 1124.
8.
LeeHKJinUSLeeYH.Subpectoral and precapsular implant repositioning technique: correction of capsular contracture and implant malposition. Aesthetic Plast Surg. 2011;35:1126-1132.
9.
HandelNCordrayTGutierrezJJensenJA.A long-term study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg. 2006;117(3):757-767.
10.
AracoAGravanteGAracoFDeloguDCervelliVWalgenbachK.A retrospective analysis of 3,000 primary aesthetic breast augmentations: postoperative complications and associated factors. Aesthetic Plast Surg. 2007;31(5):532-539.
11.
CunninghamBMcCueJ.Safety and effectiveness of Mentor’s MemoryGel implants at 6 years. Aesthetic Plast Surg. 2009;33(3):440-444.
US Food and Drug Administration. Summary of safety and effectiveness data: Allergan (formerly McGhan and Inamed) RTV saline-filled breast implants. Date unknown. https://www.accessdata.fda.gov/cdrh_docs/pdf/P99074b.pdf. Accessed February 14, 2018.
14.
US Food and Drug Administration. Summary of safety and effectiveness data: Allergan (formerly Inamed) Natrelle silicone gel-filled implants. Date unknown. https://www.accessdata.fda.gov/cdrh_docs/pdf2/P020056b.pdf. Accessed February 14, 2018.
SpearSLMurphyDKSlictonAWalkerPS.Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007;120(7)(supp 1):8S-16S; discussion 17S-18S.
US Food and Drug Administration. Summary of safety and effectiveness data: Natrelle 410 highly cohesive anatomically shaped silicone implants. Date unknown. https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040046b.pdf. Accessed February 14, 2018.
HammondDCMiglioriMMCaplinDAGarciaMEPhillipsCA.Mentor Contour Profile Gel implants: clinical outcomes at 6 years. Plast Reconstr Surg. 2012;129(6):1381-1391.
21.
MaxwellGPVan NattaBWMurphyDKSlictonABengtsonBP.Natrelle style 410 form-stable silicone breast implants: core study results at 6 years. Aesthet Surg J. 2012;32:709-717.
22.
BengstonBPVan NattaBWMurphyDKSlictonAMaxwellGP.Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg. 2007;120(7)(suppl 1):40S-48S.
23.
PrantlLSchremlSFichtner-FeiglSet al. Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg. 2007;120(1):275-284.
24.
TaylorCWHorganKDodwellD.Oncological aspects of breast reconstruction. Breast. 2005;14:118-130.
25.
CordeiroPGMcCarthyCM.A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: Part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006;118(4):832-839.
26.
CordeiroPGPusicALDisaJJMcCormickBVanZeeK.Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg. 2004;113(3):877-881.
27.
BehranwalaKADuaRSRossGMWardAA’hernRGuiGP.The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg. 2006;59(10):1043-1051.
28.
FureyPCMacgillivrayDCCastiglioneCLAllenL.Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol. 1994;55(3):194-197.
29.
CaffoOCazzolliDScaletAet al. Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat. 2000;60(3):267-275.
30.
AllweisTMBoisvertMEOteroSEPerryDJDubinNHPriebatDA.Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy. Am J Surg. 2002;183(3):218-221.
31.
MortensonMMSchneiderPDKhatriVPet al. Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg. 2004;139(9):998-991.
32.
WilsonCRBrownIMWeiller-MithoffEGeorgeWDDoughtyJD.Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy. Eur J Surg Oncol. 2004;30(6):624-627.
33.
GouySRouzierRMissanaMCAttalahDYoussefOBarreau-PouhaerL.Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival. Ann Surg Oncol. 2005;12(2):161-166.
34.
PajkosADevaAKVickeryKCopeCChangLCossartYE.Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111(5):1605-1611.
35.
AdamsWPJrRiosJLSmithSJ.Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast Reconstr Surg. 2006;117(1):30-36.
36.
BarnsleyGPSigurdsonLJBarnsleySE.Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2006;117(7):2182-2190.
37.
WongCHSamuelMTanBKSongC.Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118(5):1224-1236.
38.
AsplundOGylbertLJurellGWardC.Textured or smooth implants for submuscular breast augmentation: a controlled study. Plast Reconstr Surg. 1996;97(6):1200-1206.
39.
BloutALMartinMDLineberryKDKettanehNAlfonsoDR.Capsular contracture rate in a low-risk population after primary augmentation mammaplasty. Aesthet Surg J. 2013;33(4):516-521.
40.
VazquezBGivenKSHoustonGC.Breast augmentation: a review of subglandular and submuscular implantation. Aesthetic Plast Surg. 1987;11(2):101-105.
41.
FreemanBS.Successful treatment of some fibrous envelope contractures around breast implants. Plast Reconstr Surg. 1972;50(2):107-113.
42.
SugimotoT.Open capsulotomy for capsular contracture: a new procedure for the prevention of recurrence. Aesthetic Plast Surg. 1982;6(4):225-230.
CollisNSharpeDT.Recurrence of subglandular breast implant capsular contracture: anterior versus total capsulectomy. Plast Reconstr Surg. 2000;106(4):792-797.
45.
YoungVL.Guidelines and indications for breast implant capsulectomy. Plast Reconstr Surg. 1998;102(3):884-891; discussion 892-894.
46.
SpearSL.Capsulotomy, capsulectomy, and implantectomy. Plast Reconstr Surg. 1993;92(2):323-324.
47.
SpearSLCarterMEGanzJC.The correction of capsular contracture by conversion to “dual-plane” positioning: technique and outcomes. Plast Reconstr Surg. 2003;112(2):456-466.
48.
RohrichRJParkerTHIII. Aesthetic management of the breast after explantation: evaluation and mastopexy options. Plast Reconstr Surg. 2007;120(1):312-315.
49.
VirdenCPDobkeMKSteinPParsonsCLFrankDH.Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesthetic Plast Surg. 1992;16:173-179.
50.
SlavinSAGoldwynRM.Silicone gel implant explantation: reasons, results, and admonitions. Plast Reconstr Surg. 1995;95(1):63-69.
51.
HardtNSYuLLaTorreGSteinbachB.Complications related to retained breast implant capsules. Plast Reconstr Surg. 1995;95(2):364-371.
52.
CopelandMKresselASpieraHHermannGBleiweissIJ.Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal. Plast Reconstr Surg. 1993;92(6):1179-1181.
53.
CostagliolaMAtiyehBSRampillonF.An innovative procedure for the treatment of primary and recurrent capsular contracture (CC) following breast augmentation. Aesthet Surg J. 2013;33:1008-1017.
54.
BakerJLJrLeVierRRSpielvogelDE.Positive identification of silicone in human mammary capsular tissue. Plast Reconstr Surg. 1982;69(1):56-60.
55.
ThomsenJLChristensenLNielsenMet al. Histologic changes and silicone concentrations in human breast tissue surrounding silicone breast prostheses. Plast Reconstr Surg. 1990;85(1):38-41.
56.
DoloresWRainerCNiederegeerHPizaHWickG.Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmunity. 2004;23(1):81-91.
57.
DestouetJMMonseesBSOserRFNemecekJRYoungVLPilgramTK.Screening mammography in 350 women with breast implants: prevalence and findings of implant complications. AJR Am J Roentgenol. 1992;159(5):973-978; discussion 979-981.
58.
deCamaraDLSheridanJMKammerBA.Rupture and aging of silicone gel breast implants. Plast Reconstr Surg. 1993;91(5):828-836.
59.
YoungVLBartellTDestouetJMMonseesBLoganSE.Calcification of breast implant capsule. South Med J. 1989;82(9):1171-1173.
60.
SiggelkowWFaridiASpiritusKKlingeURathWKlosterhalfenB.Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials. 2003;24:1101-1109.
61.
WalterPSmithD.Calcification of breast implant capsules: incidence, diagnosis, and contributing factors. Ann Plast Surg. 1995;34(1):8-11.
62.
WalterPPritzkerKSmithDet al. Capsular calcification associated with silicone breast implants: incidence, determinants, and characterization. Ann Plast Surg. 1998;41(4):348-360.
63.
TanakaYMorishimaIKikuchiK.Invasive micropapillary carcinomas arising 42 years after augmentation mammoplasty: a case report and literature review. World J Surg Oncol. 2008;6(33):1-5.
64.
NelsonNJ.Silicone breast implants not linked to breast cancer risk. J Natl Cancer Inst. 2000;92(21):1714-1715.
65.
PalettaCPalettaFXJrPalettaFXSr. Squamous cell carcinoma following breast augmentation. Ann Plast Surg. 1992;29(5):425-432.
66.
KitchenSBPalettaCEShehadiSIBauerWC.Epithelialization of the lining of a breast implant capsule: possible origin of squamous cell carcinoma associated with a breast implant capsule. Cancer. 1994;73(5):1449-1452.
67.
RothFSFelderJMFriedmanJD.Breast capsulectomy specimens and their clinical implications. Plast Reconstr Surg. 2010;126(6):1848-1812.
68.
SantanellidiPompeoFLaportaRSorotosMet al. Breast implant-associated anaplastic large cell lymphoma: proposal for a monitoring protocol. Plast Reconstr Surg. 2015;136(2):144e-151e.
69.
GidengilCAPredmoreZMattkeSvan BusumKKimB.Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135(3):713-720.
70.
DuvicMMooreDMenterAVonderheidEC.Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995;32:939-942.
71.
CohenPLBrooksJJ.Lymphomas of the breast: a clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer. 1991;67:1359-1369.
ReidGBaileyRR.Biofilm infections: implications for diagnosis and treatment. N Z Med J. 1996;109(1016):41-42.
74.
FreedmanAMJacksonIT.Infections in breast implants. Infect Dis Clin North Am. 1989;3(2):275-287.
75.
BurkhardtBRDempseyPDSchnurPLTofieldJJ.Capsular contracture: a prospective study of the effect of local antibacterial agents. Plast Reconstr Surg. 1986;77(6):919-932.
76.
DobkeMKSvahnJKVastineVLLandonBNSteinPCParsonsCL.Characterization of microbial presence at the surface of silicone mammary implants. Ann Plast Surg. 1995;34(6):563-569; discussion 570-571.
77.
TakayanagiSNakagawaCSugimotoY.Augmentation mammaplasty: where should the implant be placed?Aesthetic Plast Surg. 2004;28(2):83-88.
78.
YalanisGCLiuEWChengHT.Efficacy and safety of povidone-iodine irrigation in reducing the risk of capsular contracture in aesthetic breast augmentation: a systematic review and meta-analysis. Plast Reconstr Surg. 2015;136(4):687-698.
79.
BurkhardtBR.Comparing contracture rates: probability therapy and the unilateral contracture. Plast Reconstr Surgery. 1984;74:527-529.
80.
SchlesingerSLEllenbogenRDesivigneMNSvehlakSHeckR.Zafirlukast (Accolate): a new treatment for capsular contracture. Aesthet Surg J. 2002;22(4):329-336.
81.
SchlesingerSLHeckRT.Letter to the editor: a new treatment for capsular contracture. Aesthet Surg J. 2002;22(2):164-165.
82.
BakerJLJr.The effectiveness of alpha-tocopherol (vitamin E) in reducing the incidence of spherical contracture around breast implants. Plast Reconstr Surg. 1981;68(5):696-698.
83.
NiessenFBSpauwenPHSchalkwijkJKonM.On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104(5):1435-1458.
84.
HuangCKHandelN.Effects of Singulair (montelukast) treatment for capsular contracture. Aesthet Surg J. 2010;30(3):404-410.
FloraKHahnMRosenHBennerK.Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998;93(2):139-143.
87.
HerhahnFT.Ultrasound and capsular contracture. Plast Reconstr Surg. 1984;74(4):574.
88.
PlanasJMiglianoEWagenfuhrJJrCastilloS.External ultrasonic treatment of capsular contractures in breast implants. Aesthetic Plast Surg. 1997;21(6):395-397.
89.
PlanasJ.Prophylactic use of external ultrasound for breast implant capsular contracture. Aesthet Surg J. 2002;22(2):205-207.
90.
PereiraANEduardoPMatsonEMarquesMM.Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med. 2002;31:263-267.
91.
VinckEMCagnieEMCornelissenMJDeclercqHACambierDC.Increased fibroblast proliferation by light emitting diode and low power laser irradiation. Lasers Med Sci. 2003;18:95-99.
92.
YuWNaimJOMcGowanMIppolitoKLanzafameRJ.Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol. 1997;66(6):866-871.
93.
SilvieraPCSilvaLAFragaDBFreitasTPStreckELPinhoR.Evaluation of mitochondria respiratory chain activity in muscle healing by low-level laser therapy. J Photochem Photobiol B. 2009;95(2):89-92.
94.
PastoreDGrecoMpetragalloVAPassarellaS.Increase in <−H+/e- ratio of the cytochrome c oxidase reaction in mitochondria irradiated with helium-neon laser. Biochem Mol Biol Int. 1994;34(4):817-826.
95.
KaruTIKolyakovSF.Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23(4):355-361.
96.
JohnsonJDGlatPMScarlettWL.Low-level laser therapy: an alternative treatment for capsular contraction. Am J Cosmet Surg. 2015;32(1):1-6.
97.
JacksonRFRocheGMangioneT.Low-level laser therapy effectiveness for reducing pain after breast augmentation. Am J Cosmet Surg. 2009;26:144-148.
98.
OmarMTShaheenAAZafarH.A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema. Support Care Cancer. 2012;20:2977-2984.
99.
FreitasCPMeloCAlexandrinoAMNoitesA.Efficacy of low-level laser therapy on scar tissue. J Cosmet Laser Ther. 2013;15:171-176.
